INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
74 hedge funds and large institutions have $53.7M invested in Infinity Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-6
Holders Change %
-7.5%
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
15
Reduced
25
Closed
22
Calls
$259K
Puts
$71K
Net Calls
+$188K
Net Calls Change
+$20K
Top Buyers
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$1.16M |
| 2 |
Millennium Management
New York
|
+$835K |
| 3 |
Legal & General Group
London,
United Kingdom
|
+$526K |
| 4 |
D.E. Shaw & Co
New York
|
+$360K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$349K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$6.36M |
| 2 |
BlackRock
New York
|
-$3.28M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.17M |
| 4 |
JPMorgan Chase & Co
New York
|
-$730K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$691K |
